Covered recipient · General Payments record
DAN J GZESH
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$10,484.03
- Reported across 297 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $4,570.00 | 1 |
| Food and Beverage | $564.00 | 20 |
| Travel and Lodging | $381.96 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| EISAI INC. | $5,175.95 | 11 |
| ARGENX US, INC. | $142.51 | 5 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $49.96 | 1 |
| ABBVIE INC. | $31.63 | 1 |
| Genentech USA, Inc. | $26.09 | 1 |
| Merz Pharmaceuticals, LLC | $20.02 | 1 |
| Alexion Pharmaceuticals, Inc. | $17.71 | 1 |
| Neurelis, Inc. | $17.53 | 1 |
| Grifols USA, LLC | $17.33 | 1 |
| Lilly USA, LLC | $17.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $31.63 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103857689 | CMS |
| Alexion Pharmaceuticals, Inc. | $17.71 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093962317 | CMS |
| ARGENX US, INC. | $27.27 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142111639 | CMS |
| ARGENX US, INC. | $27.21 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142108781 | CMS |
| ARGENX US, INC. | $32.05 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142122132 | CMS |
| ARGENX US, INC. | $31.59 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142120215 | CMS |
| ARGENX US, INC. | $24.39 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142125785 | CMS |
| Eisai Inc. | $63.41 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110738163 | CMS |
| Eisai Inc. | $222.31 | 06/21/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110738173 | CMS |
| Eisai Inc. | $16.70 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110738179 | CMS |
| Eisai Inc. | $36.37 | 06/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110738165 | CMS |
| Eisai Inc. | $49.95 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110738167 | CMS |
| Eisai Inc. | $17.97 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110738169 | CMS |
| Eisai Inc. | $12.37 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110738171 | CMS |
| Eisai Inc. | $47.28 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110738175 | CMS |
| Eisai Inc. | $16.31 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110738177 | CMS |
| Eisai Inc. | $4,570.00 | 07/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110738183 | CMS |
| Eisai Inc. | $123.28 | 08/02/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110738181 | CMS |
| Genentech USA, Inc. | $26.09 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132993076 | CMS |
| Grifols USA, LLC | $17.33 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124715113 | CMS |
| Lilly USA, LLC | $17.23 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136138665 | CMS |
| Merz Pharmaceuticals, LLC | $20.02 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137948052 | CMS |
| Neurelis, Inc. | $17.53 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145642874 | CMS |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $49.96 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118837009 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.